Compare · AGPU vs STE
AGPU vs STE
Side-by-side comparison of Axe Compute Inc. (AGPU) and STERIS plc (Ireland) (STE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AGPU and STE operate in Industrial Specialties (Health Care), so they compete in similar markets.
- STE is the larger of the two at $21.75B, about 591.4x AGPU ($36.8M).
- Over the past year, AGPU is down 58.3% and STE is down 1.5% - STE leads by 56.8 points.
- AGPU has been more active in the news (13 items in the past 4 weeks vs 3 for STE).
- STE has more recent analyst coverage (16 ratings vs 0 for AGPU).
- Company
- Axe Compute Inc.
- STERIS plc (Ireland)
- Price
- $6.63-7.40%
- $221.72-0.76%
- Market cap
- $36.8M
- $21.75B
- 1M return
- +292.60%
- -0.80%
- 1Y return
- -58.27%
- -1.52%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 13
- 3
- Recent ratings
- 0
- 16
STERIS plc (Ireland)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.
Latest AGPU
- SEC Form 4 filed by Nuzum Charles Lee Sr
- SEC Form 4 filed by Rao Veena
- SEC Form 4 filed by Matthews Shawn
- SEC Form 4 filed by St. Clair Gregory Sr
- SEC Form 4 filed by Hawryluk Matthew
- SEC Form 4 filed by Handley Daniel E
- Axe Compute Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Axe Compute Secures $260 million, Three-Year Enterprise Contract for 2,304-GPU NVIDIA B300 Deployment
- SEC Form 4 filed by Yaukey-Witter Jeremy Reese
- SEC Form 3 filed by new insider Yaukey-Witter Jeremy Reese
Latest STE
- STERIS to Host a Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results on May 12, 2026
- Teleflex Announces Governance Updates
- SEC Form 8-K filed by STERIS plc (Ireland)
- Amendment: SEC Form SCHEDULE 13G/A filed by STERIS plc (Ireland)
- Director Feldmann Cynthia L exercised 3,098 units of Ordinary Shares at a strike of $152.32 and sold $734,877 worth of Ordinary Shares (3,098 units at $237.21) (SEC Form 4)
- SEC Form 144 filed by STERIS plc (Ireland)
- SEC Form 10-Q filed by STERIS plc (Ireland)
- STERIS plc (Ireland) filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- STERIS Announces Financial Results for Fiscal 2026 Third Quarter
- STERIS Announces Dividend of $0.63 per share